Sandoz strengthens pipeline expansion through partnership to develop and manufacture multiple biosimilars
The Pharma Data
MAY 15, 2023
Access to Just – Evotec Biologics’ highly efficient drug substance development platform and manufacturing technology complements Sandoz capabilities, supporting expansion of the current pipeline from 15+ to 24 assets and the continued development of its early-stage biosimilar pipeline.
Let's personalize your content